Inovio Pharmaceuticals Inc
NASDAQ:INO

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
NASDAQ:INO
Watchlist
Price: 4.07 USD 0.25% Market Closed
Market Cap: 105.7m USD
Have any thoughts about
Inovio Pharmaceuticals Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-0.2
Current
-0.7
Median
5.7
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-0.2
=
Enterprise Value
21.2m USD
/
Operating Cash Flow
-110.7m USD
All Countries
Close
 
US
Inovio Pharmaceuticals Inc
NASDAQ:INO
Average EV/OCF: 22.8
Negative Multiple: -0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 317.7
US
Abbvie Inc
NYSE:ABBV
22
US
Amgen Inc
NASDAQ:AMGN
28.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -128.5
US
Gilead Sciences Inc
NASDAQ:GILD
10.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.5
AU
CSL Ltd
ASX:CSL
34.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126.8

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More